ABOUT RANBAXY

ABOUT RANBAXY TOTAL OVERVIEW

1. COMPANY SELECTED: - “RANBAXY LABORATORIES LTD”

2. Strengths & weakness of Ranbaxy   STRENGTHS Multi-disciplinary R&D centers . Worldwide presence. Operations in more than 50+ countries & Generic products in 125+ countries . Now Sun Pharma support .       WEAKNESS More dependent on generic drugs. Efficiency is affected by Govt. regulatory. Lack of effective marketing strategies. Direct to customer advertisement is almost nil. My view on company’s Mission & Values Statements The mission followed by the company is quiet clear as it has a reach to customers over 150 countries and yet to reach more. Changing lifestyle has led to change in disease patterns, and increased demand for new quality medicines to combat lifestyle related diseases for what Ranbaxy is trying to provide these quality medicines at an affordable cost’s. Financial losses disturbed the company which made Ranbaxy to be get sold to Sunpharma Ltd.

3. S trategies and Value chain analysis... VALUE CHAIN ANALYSIS The value chain analysis at this company is like a Hybrid business model. This unique business model brings together the complementary strengths of a global generic company (Ranbaxy) and a top global innovator (Daiichi Sankyo ). FUNCTIONAL STRATEGIES There are working with various teams on manufacturing, R&D, etc., to assess per-month productivity of each department. Strong emphasis is being given to effective cross-functional teamwork, with a view to inculcate a vibrant, enabling and empowering work culture . INTERNAL ANALYSIS It is heavily dependent upon generics for its revenue generation. The company has applied rigid quality measures at every stage of manufacturing at their plants.   EXTERNAL ANALYSIS Redefine our business model, bringing in Daiichi Sankyo Co., Ltd. as a majority partner to create a strategic combination of a giant innovator and a generic powerhouse.